Recent Trends in the Synthesis and Bioactivity of Coumarin, Coumarin-Chalcone, and Coumarin-Triazole Molecular Hybrids

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2024 Mar 13

PMID 38474540

Authors

Nur Rohman

Bayu Ardiansah

Tuti Wukirsari

Zaher Judeh

Affiliations

Soon will be listed here.

Abstract

Molecular hybridization represents a new approach in drug discovery in which specific chromophores are strategically combined to create novel drugs with enhanced therapeutic effects. This innovative strategy leverages the strengths of individual chromophores to address complex biological challenges, synergize beneficial properties, optimize pharmacokinetics, and overcome limitations associated with single-agent therapies. Coumarins are documented to possess several bioactivities and have therefore been targeted for combination with other active moieties to create molecular hybrids. This review summarizes recent (2013-2023) trends in the synthesis of coumarins, as well as coumarin-chalcone and coumarin-triazole molecular hybrids. To cover the wide aspects of this area, we have included differently substituted coumarins, chalcones, 1,2,3- and 1,2,4-triazoles in this review and considered the point of fusion/attachment with coumarin to show the diversity of these hybrids. The reported syntheses mainly relied on well-established chemistry without the need for strict reaction conditions and usually produced high yields. Additionally, we discussed the bioactivities of the reported compounds, including antioxidative, antimicrobial, anticancer, antidiabetic, and anti-cholinesterase activities and commented on their IC where possible. Promising bioactivity results have been obtained so far. It is noted that mechanistic studies are infrequently found in the published work, which was also mentioned in this review to give the reader a better understanding. This review aims to provide valuable information to enable further developments in this field.

Citing Articles

Elucidating the Mechanism of Coumarin Homodimerization Using 3-Acetylcoumarin Derivatives.

Simeonova K, Koleva A, Petkova-Yankova N, Zlatanova A, Lozanova V, Nikolova R Molecules. 2025; 30(3).

PMID: 39942755 PMC: 11820059. DOI: 10.3390/molecules30030651.

Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies.

Priya S, Islam M, Kasana S, Kurmi B, Gupta G, Patel P Future Med Chem. 2025; 17(4):449-465.

PMID: 39886772 PMC: 11834451. DOI: 10.1080/17568919.2025.2458450.

Mechanistic Aspects of [3+2] Cycloaddition Reaction of Trifluoroacetonitrile with Diarylnitrilimines in Light of Molecular Electron Density Theory Quantum Chemical Study.

Lapczuk A, Rios-Gutierrez M Molecules. 2025; 30(1.

PMID: 39795142 PMC: 11722534. DOI: 10.3390/molecules30010085.

Mechanistic Insights into the Stimulatory Effect of Melanogenesis of 4-Methylcoumarin Derivatives in B16F10 Melanoma Cells.

Lee Y, Hyun C Int J Mol Sci. 2024; 25(22).

PMID: 39596485 PMC: 11594713. DOI: 10.3390/ijms252212421.

Step-by-step synthetic route to access eugenol-1,2,3-triazole-chalcone hybrid.

Ullah A, Ardiansah B, Cahyana A, Ali A MethodsX. 2024; 13:102956.

PMID: 39329152 PMC: 11426147. DOI: 10.1016/j.mex.2024.102956.

References

Park J, Ko J, Kim D, Kim Y, Kwon H, Jae Jeong H . Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem. 2015; 31(1):23-30. DOI: 10.3109/14756366.2014.1003215. View

Jasim H, Nahar L, Jasim M, Moore S, Ritchie K, Sarker S . Chalcones: Synthetic Chemistry Follows Where Nature Leads. Biomolecules. 2021; 11(8). PMC: 8392591. DOI: 10.3390/biom11081203. View

Sharifi-Rad J, Cruz-Martins N, Lopez-Jornet P, Pons-Fuster Lopez E, Harun N, Yeskaliyeva B . Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms. Oxid Med Cell Longev. 2021; 2021:6492346. PMC: 8440074. DOI: 10.1155/2021/6492346. View

Khan F, Elhiday A, Khudair I, Yousef H, Omran A, Alsamman S . Evaluation of the use of piperacillin/tazobactam (Tazocin) at Hamad General Hospital, Qatar: are there unjustified prescriptions?. Infect Drug Resist. 2012; 5:17-21. PMC: 3269129. DOI: 10.2147/IDR.S27965. View

Nepali K, Sharma S, Sharma M, Bedi P, Dhar K . Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem. 2014; 77:422-87. DOI: 10.1016/j.ejmech.2014.03.018. View

Chai X, Zhang J, Yu S, Hu H, Zou Y, Zhao Q . Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols. Bioorg Med Chem Lett. 2009; 19(6):1811-4. DOI: 10.1016/j.bmcl.2009.01.048. View

Viegas-Junior C, Danuello A, da Silva Bolzani V, Barreiro E, Fraga C . Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem. 2007; 14(17):1829-52. DOI: 10.2174/092986707781058805. View

Franceschelli S, Pesce M, Vinciguerra I, Ferrone A, Riccioni G, Patruno A . Licocalchone-C extracted from Glycyrrhiza glabra inhibits lipopolysaccharide-interferon-γ inflammation by improving antioxidant conditions and regulating inducible nitric oxide synthase expression. Molecules. 2011; 16(7):5720-34. PMC: 6264366. DOI: 10.3390/molecules16075720. View

Vazquez-Rodriguez S, Lama Lopez R, Matos M, Armesto-Quintas G, Serra S, Uriarte E . Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis. Bioorg Med Chem. 2015; 23(21):7045-52. DOI: 10.1016/j.bmc.2015.09.028. View

10.

Annunziata F, Pinna C, Dallavalle S, Tamborini L, Pinto A . An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities. Int J Mol Sci. 2020; 21(13). PMC: 7370201. DOI: 10.3390/ijms21134618. View

11.

Emam S, Sonousi A, Osman E, Hwang D, Kim G, Hassan R . Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells. Bioorg Chem. 2021; 107:104630. DOI: 10.1016/j.bioorg.2021.104630. View

12.

Weng K, Yuan Y . Synthesis and evaluation of coumarin derivatives against human lung cancer cell lines. Braz J Med Biol Res. 2017; 50(11):e6455. PMC: 5597286. DOI: 10.1590/1414-431X20176455. View

13.

Constantinescu T, Lungu C . Anticancer Activity of Natural and Synthetic Chalcones. Int J Mol Sci. 2021; 22(21). PMC: 8582663. DOI: 10.3390/ijms222111306. View

14.

Boechat N, Ferreira V, Ferreira S, Ferreira M, de C da Silva F, Bastos M . Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain. J Med Chem. 2011; 54(17):5988-99. DOI: 10.1021/jm2003624. View

15.

Srinivasan B, Johnson T, Lad R, Xing C . Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. J Med Chem. 2009; 52(22):7228-35. DOI: 10.1021/jm901278z. View

16.

Amin K, Eissa A, Abou-Seri S, Awadallah F, Hassan G . Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. Eur J Med Chem. 2013; 60:187-98. DOI: 10.1016/j.ejmech.2012.12.004. View

17.

Vogel S, Barbic M, Jurgenliemk G, Heilmann J . Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Eur J Med Chem. 2010; 45(6):2206-13. DOI: 10.1016/j.ejmech.2010.01.060. View

18.

Fu Y, Hsieh T, Guo J, Kunicki J, Lee M, Darzynkiewicz Z . Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun. 2004; 322(1):263-70. DOI: 10.1016/j.bbrc.2004.07.094. View

19.

Song X, Fan J, Liu L, Liu X, Gao F . Coumarin derivatives with anticancer activities: An update. Arch Pharm (Weinheim). 2020; 353(8):e2000025. DOI: 10.1002/ardp.202000025. View

20.

Sashidhara K, Kumar M, Modukuri R, Sonkar R, Bhatia G, Khanna A . Synthesis and anti-inflammatory activity of novel biscoumarin-chalcone hybrids. Bioorg Med Chem Lett. 2011; 21(15):4480-4. DOI: 10.1016/j.bmcl.2011.06.002. View